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1. Introduction 
In the course of our work investigating the 
stereochemistry and biological activity of the metab- 
olite of vitamin D3, 25,26-dihydroxycholecalciferol 
25,36(OH)2D3, isolated from porcine [ 1] and human 
[2] plasma, we have synthesized [3] the C-25 eplmers 
of the latter and established [4] their absolute 
configuration. One of these epimers, 35R,26- or 
25S,26(OH)2D3, must be identical with the natural 
product. 
The biological activity of 35R,26- and 35S,26(OH)2D3 
was examined [3] in rachitic rats and the latter epimer 
was found superior to the former in elevating serum 
phosphorus and in the cure of rickets. These results 
led us to undertake the synthesis [5] of the unknown 
epimeric 26-hydroxy-derivatives ofvitamin D3, (25R)- 
and (25S)-26-OH-D3, which may be helpful in defining 
more clearly the relation between the 36-hydroxyl 
and biological activity. 
This paper reports the biological activity of (25R)- 
and (25S)-26-OH-Da on bone and gut in vitamin D-de- 
ficient rats. We describe also the effects of 25R,26- and 
25S,26(OH),D3 on intestinal calcium transport, not 
reported in [3]. These results make comparisons 
between the 25R and 25s epimers of either 26-OH-D3 
or 25,26(OH)*Ds possible. 
2. Materials and methods 
Biological methods were detailed in [6]. 
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2.1 . Cllenlical conzpoutds 
3.1.1. 25R,26- and 25S,36(OH),D3 
These compounds were prepared as m [3.4]. 
2.1.2. (25R)- and (25S)-26-OH-D3 
These compounds were obtained by chemical syn- 
thesis from (25R)- and (75S)-36-hydroxycholesterol 
[5.71. 
2.2. Animals ard diets 
Weanling Sprague-Dawley male rats were fed for 
4 weeks on a synthetic vttamm D-free diet containing 
0.47% Ca2+ and 0.30% P. Then the animals were kept 
for a further week either on a low Ca2+ (< 0.0%) 
vitamin D-free diet for experiments measuring intes- 
tinal Ca2+ transport and bone Ca2+ mobilization, or a 
low phosphorus (< 0.01%) vitamin D-free diet for 
experiments investigating bone calcification and 
serum phosphorus variation. 
2.3. AtlaljPtical proceduws 
Calcium was measured by atomic absorption 
(Perkin-Elmer 303) in presence of 1% of L&l,. 
Pi was determined according to [8]. Radioactivity 
was measured using a liquid scintillation counter 
(Intertechnique SL 40) and 45Ca2+ was counted m 
Instagel solution (Packard). 
2.4. It1 vitro itltestitial Ca2+ tratwport 
This was measured by the everted gut sac tech- 
nique [9] and the results expressed as the 45Ca2+ con- 
centration inside/outside ratio. 
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2.5. BoJle Ca2+ mobilization 
The increase of serum Ca2+ 24 h after injection is 
regarded as resulting from the mobilization of bone 
Ca’+. 
2.9. Statistical arlalysis 
Analysis for statistical significance was performed 
by Wilcoxon’s nonparametric test. 
2.6. Calcificatiorl of bone 
This was measured by the line-test [lo] 1 week 
after the administration of compounds. 
2.7. Serum phosphorus 
This was determined 1 week after the administra- 
tion of compounds. 
2.8. Administration of compounds 
Table 1 shows the effects of 250 ng (corresponding 
to 10 IU) of (25R)-26-OH-D3 and (25S)-26-OH-D3 on 
bone. In vitamin D- and phosphorus-deficient rats 
only the 25R epimer is effective in elevating serum 
phosphorus and in stimulating bone calcification, 
while in vitamin D- and Ca2’deprived animals neither 
25R nor 25s induce bone resorption. 
Epimers of either 26-OH-D3 or 25 ,26(OH),D3 Tables 2 and 3 illustrate the effects of 250 ng 
(250 ng) were dissolved in ethanol (50 ~1) and injected C-25 epimers of either 26-OH-D3 or 25,26(OH)=Ds on 
intravenously. Controls were tested with ethanol intestinal Ca*+ transport in vitamin D- and Ca”-defi- 
(50 Pl). cient rats. While 25R,26- and 25S,26(OH),Ds are both 
3. Results 
Table 1 
Effects of the epimers of 26-OH-D, on bone Ca* mobilization, serum phosphorus and bone calcification 
Compound Bone Ca” mobihzation Serum phosphorus (mg/l) Bone calcification 
(serum calcium mg/l) Mean k SD (Epiphyseal calcification score) 
Mean f SD Mean ? SD 
75.75 k 4.79 
25-OH-D, (125 ng) (4) 
w: = 10 p = 0.05 
48.00 + 3.40 
(25R)-26_OH-D, (250 ng) (6) 
W;= 14 NS 
50.33 f 2.87 
(25S)-26-OH-D, (250 ng) (6) 
W:=21 NS 
Control (50 ~1 ethanol) 
47.23 ? 2.22 
(4) 
38.$7 + 2.99 
(7) 
W; = 28 p < 0.01 
32.00 k 3.00 
(7) 
w: = 31 p < 0.01 
26.14 * 2.79 
(7) 
W;=47.5 NS 
26.86 + 2.48 
(7) 
3.12 * 0.05 
(8) 
W; = 28 p < 0.01 
1.87 + 0.95 
(8) 
W; = 29 p < 0.01 
oto 
(8) 
0.07 * 0.19 
(7) 
Table 2 
Effects of the epimers of 26-OH-D, on intestinal CaZI transport 
Control (50 ~1 ethanol) Inside/outside ratio. Mean A SD 
25-OH-D, (250 ng) (25R)-26-OH-D, (250 ng) (25S)-26-OH-D, (250 ng) 
0.87 + 0.05 
(4) 
1.93 + 0.08 1.03 + 0.03 0.95 f 0.07 
(4) (6) (6) 
ru: = 10 p = 0.05 w;=10 p=O.Ol W;t = 15 NS 
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Effects of the epimers of 25,26(0H),D, on intestinal Ca” transport 
Control (50 ~1 ethanol) Inside/outside ratio. Mean ? SD 
25-OH-D, (250 ng) 25R,26(OH),D, (250 ng) 25S,26(OH),D, (250 ng) 
0.9 * 0.01 1.90 t 0.11 0.99 c 0.05a 1.15 * 0.14a 
(4) (4) (6) (6) 
w:: = 10 p = 0.05 w; = 11.5 p < 0.05 w; = 10 p = 0.01 
a Difference between 25R,26- and 25S,26(OH),D, was significant (p = 0.05) 
effective (the latter significantly @ = 0.05) more than 
the former) only (25R)-26OH-D3 stimulates Ca2+ 
absorption. 
4. Discussion 
Our results demonstrate that among the 26hydroxy- 
derivatives of vitamin D3 the biological activity depends 
upon the configuration at C-25 and the 25R epimer: 
(25R)-26-OH-D3 is more effective on bone and gut 
than the 25s one: (25S)26-OH-D3. We have investigated 
[3] the relation between C-25 configuration and 
biological response’ with respect to the 25,26-d&y- 
droxy-derivatives of vitamin Da: 25R,26- and 
25S,26(OH)2D3 and found the latter biologically 
superior to the former. 
The fact that the more effective epimers of either 
26-OH-D3 or 25 ,26(OH)2D3: (25R)-26-OH-D3 and 
25S,26(OH)2Da, respectively, bear opposite signs of 
conventional configuration at C-25, can be probably 
explained by their metabolic relationship and the 
rules of nomenclature [ 111. 
Indeed, 26-hydroxy-derivatives of vitamin D3 are 
very likely to be converted by a hepatic hydroxylase 
system [12] into 25,26_dihydroxyderivatives (similar 
metabolic hydroxylation at C-25 has been reported for 
24-hydroxyvitamin D3 [ 131) and this reaction gener- 
ally proceeds with retention [ 141 of spatial configura- 
tion. But introduction of the hydroxyl into the asym- 
metric centre C-25 induces inversion of conventional 
signs (R or S) in accordance with the rules of nomen- 
clature [I I]. 
From the foregoing it may be concluded that metab- 
olic hydroxylation of (25R)- and (25S)-26-011-D3 
should yield 258,26-and 25R,26(OH)2D3, respectively. 
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In other words, (25R)-%-OH-D3 and 25S,26(0H),D3 
on the one hand,(25S)-26-OH-D, and 25R,26(OH),D3 
on the other hand, should have similar spatial configu- 
ration and activity. 
Our biological results support this conclusion. 
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